Dermatology Times, June 2026 (Vol. 47. No. 06)

In clinical practice, digital twins could predict how individual patients respond to treatments based on factors such as genetics, skin barrier function, and lifestyle patterns.

A phase 2 clinical trial found that topical ruxolitinib cream showed promising efficacy and safety in patients with mild to moderate hidradenitis suppurativa.

The June issue of Dermatology Times highlights the latest advances in skin cancer, psoriasis, atopic dermatitis, hidradenitis suppurativa, and emerging dermatology technologies.

Rapid GLP-1 weight loss can age the face—a new paper reviews multimodal nonsurgical fixes with fillers, Botox, devices, and skin care for natural balance.

Resource-poor environments exist not only globally but also in everyday settings like nursing homes, prisons, foster care, and low-income households.